Prestigious Award Recognizes Groundbreaking Immune System Research
The prestigious award in medical science has been awarded for transformative findings that clarify how the immune system targets harmful infections while protecting the body's own cells.
A trio of esteemed scientists—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—share this honor.
The work identified unique "sentinels" within the defense system that eliminate rogue defense cells capable of harming the organism.
These findings are now paving the way for new treatments for immune disorders and malignancies.
These laureates will share a prize fund worth 11 million SEK.
Decisive Discoveries
"The research has been essential for comprehending how the body's defenses functions and the reason we don't all suffer from serious self-attack conditions," commented the head of the award panel.
This trio's research explain a core question: In what way does the defense system protect us from countless infections while leaving our healthy cells intact?
Our body's protection system employs immune cells that search for signs of infection, even pathogens and germs it has never encountered.
These cells employ detectors—known as recognition units—that are produced by chance in a vast number of combinations.
That gives the defense network the capacity to fight a wide array of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the body.
Protectors of the Immune System
Researchers previously knew that a portion of these harmful defense cells were eliminated in the immune organ—the site where white blood cells develop.
The latest Nobel Prize recognizes the identification of T-reg cells—described as the immune system's "peacekeepers"—which travel through the system to neutralize any immune cells that attack the body's own tissues.
It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.
A Nobel panel added, "These findings have laid the foundation for a new field of investigation and accelerated the creation of new treatments, for instance for tumors and immune disorders."
Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so studies are aimed at reducing their quantity.
In autoimmune diseases, experiments are testing boosting T-reg cells so the body is no longer under attack. A comparable approach could also be useful in reducing the risks of organ transplant rejection.
Pioneering Studies
Prof Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their immune gland removed, leading to autoimmune disease.
The researcher demonstrated that injecting immune cells from other animals could stop the disease—suggesting there was a mechanism for preventing immune cells from harming the host.
Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an genetic autoimmune disease in mice and people that resulted in the discovery of a gene vital for how regulatory T-cells function.
"Their pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the body's own tissues," commented a leading biological science specialist.
"The research is a striking illustration of how basic biological study can have broad implications for public health."
